Clinical Trials Browser

Phase 2 × Lymphoma, Follicular × tafasitamab × Clear all

NCT06792825 2025-08-12

HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL

Phase 2 Recruiting

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone